Invest in Transdermal Specialties Global
TSG has created a Patented transdermal Insulin delivery patch for diabetics (both Type 1 & Type 2)
Highlights
1
Innovative life-sustaining technology providing needle-free drug delivery for diabetes control
2
The team has unique C-Level experience in pharma, biotech, and medical device product develo
3
300 subjects studied in the US and S. Korea. Their blood sugar levels are controlled.
4
300 subjects involved in clinical trials in the US and S. Korea. Only phase 3 is required for FDA
Featured Investors
Invested $4,000,002
Invested $2 this round & $4,000,000 previously
Win Pac Inc.. is engaged in semiconductor business. The company provides package products and testing services such as fine pitch ball grid array (FBAG), land grid array (LGA), package on package (POP), flip chips as well as testing services.
“We are excited about partnering with TSG!”
![[object Object] profile photo](https://uploads.wefunder.com/2021/user_default_icon_circle.png){kind=icon}
Other investors include ,
Our Team
Founder, President & CEO
Former Mission Specialist for the Space Program
Developer of the U-Strip System
Holds Numerous Patents in the Controlled Release Field
Licensor & Technology transfer agreements with DuPont, ConAgra, General Mills, Nabisco, and GNC. Over 65 Patents
Michael WirthCFO
Michael J Wirth is a successful financial executive with over 50+ years of diversified experience - positions at private and public companies - encompassing leadership roles from Controller to CFO, Responsible for Accounting, Finance, & Human Resources
Marketing Director
Mr. Butcher has served as VP of Sales and Marketing for Over 20 years. His experience in Marketing Controlled release technology and products. He has served on several Boards of Directors including M-Cap Technologies, (a Dupont Conagra JV).
Pioneering Ultrasonic Drug Delivery Systems
